Seattle Genetics (SGEN)
53.29
-2.04 -3.69%
NASDAQ
Sep 29, 20:00
Delayed 2m
USD
View All Key Stats
SGEN Key Stats
| Income Statement | |
| Revenue (TTM) | 384.11M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.76 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -104.52M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 89.51% |
| Profit Margin (Quarterly) | -34.32% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 7.488B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 18.99 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 11.20 |
| Other | |
| Beta | Upgrade |
| Debt to Equity Ratio (Quarterly) | -- |
| Free Cash Flow (Quarterly) | -35.84M |
| Return on Equity (TTM) | -17.93% |
View All SGEN News
SGEN News
-
WireHeadlineTime (ET)
-
Yahoo09/27 06:19
-
Yahoo09/24 12:09
-
Yahoo09/22 10:52
-
MT Newswires09/20 11:52
-
MT Newswires09/19 09:01
-
Yahoo09/19 08:01
-
Business Wire09/19 08:00
-
Yahoo09/18 10:02
-
MT Newswires09/16 22:13
-
MT Newswires09/16 14:46
View All Events
SGEN Events
| Date | Type | Description |
|---|---|---|
| 07/26/2016 16:30 EDT | Misc | Seattle Genetics Inc Second Quarter Earnings Conference Call in 2016 |
| 07/26/2016 | Earnings | Seattle Genetics Inc Second Quarter Earnings in 2016 Release |
| 05/20/2016 | Misc | Seattle Genetics Inc Annual General Meeting in 2015 |
| 04/28/2016 16:30 EDT | Misc | Seattle Genetics Inc First Quarter Earnings Conference Call in 2016 |
| 04/28/2016 | Earnings | Seattle Genetics Inc First Quarter Earnings in 2016 Release |
| 02/09/2016 16:30 EST | Misc | Seattle Genetics Inc Fourth Quarter Earnings Conference Call in 2015 |
| 02/09/2016 | Earnings | Seattle Genetics Inc Fourth Quarter Earnings in 2015 Release |
| 10/29/2015 16:30 EDT | Misc | Seattle Genetics Inc Third Quarter Earnings Conference Call in 2015 |
| 10/29/2015 | Earnings | Seattle Genetics Inc Third Quarter Earnings in 2015 Release |
SGEN Fundamentals
Income Statement View Statement
SGEN Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
One Page Reports
- One Page Report Download
Edit
Profile
- URL: http://www.seattlegenetics.com
- Investor Relations URL: http://investor.seattlegenetics.com/phoenix.zhtml?c=124860&p=irol-IRHome
- HQ State/Province: Washington
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: July 26, 2016
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Seattle Genetics Inc is a biotechnology company. It develops and commercializes monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease.
SGEN Comparables
EditSGEN Excel Add-In Codes
- Name: =YCI("SGEN","name")
- Description: =YCI("SGEN","description")
- Sector: =YCI("SGEN","sector")
- Industry: =YCI("SGEN","industry")
- Est. Current Fiscal Year End: =YCI("SGEN","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other SGEN Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- SGEN Tweets Stocktwits
Advertisement